ArticleBreast care (Basel, Switzerland)2026

Treatment Experience of Early-Stage Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer in a Real-World Setting: European Patients' Perspectives.

Maggie Banys-Paluchowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.